Antibody-drug conjugates: fundamentals, drug development, and clinical outcomes to target cancer
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Hoboken, New Jersey
Wiley
[2017]
|
| Schlagworte: | |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | xxxiv, 521 Seiten Illustrationen, Diagramme |
| ISBN: | 9781119060680 |
Internformat
MARC
| LEADER | 00000nam a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV044557919 | ||
| 003 | DE-604 | ||
| 005 | 20180409 | ||
| 007 | t | ||
| 008 | 171026s2017 a||| |||| 00||| eng d | ||
| 020 | |a 9781119060680 |c Print |9 978-1-119-06068-0 | ||
| 035 | |a (OCoLC)974721534 | ||
| 035 | |a (DE-599)BVBBV044557919 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-473 |a DE-19 | ||
| 082 | 0 | |a 615.7/98 | |
| 084 | |a VS 9400 |0 (DE-625)147728:253 |2 rvk | ||
| 100 | 1 | |a Olivier, Kenneth J. |c Jr. |d 1968- |e Verfasser |0 (DE-588)112590271X |4 aut | |
| 245 | 1 | 0 | |a Antibody-drug conjugates |b fundamentals, drug development, and clinical outcomes to target cancer |c edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz |
| 264 | 1 | |a Hoboken, New Jersey |b Wiley |c [2017] | |
| 300 | |a xxxiv, 521 Seiten |b Illustrationen, Diagramme | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Includes bibliographical references and index | ||
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Antibody-toxin conjugates | |
| 700 | 1 | |a Hurvitz, Sara A. |d 1970- |e Sonstige |0 (DE-588)1125902795 |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-119-06072-7 |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-029956597 | ||
Datensatz im Suchindex
| _version_ | 1804177926871056384 |
|---|---|
| any_adam_object | |
| author | Olivier, Kenneth J. Jr. 1968- |
| author_GND | (DE-588)112590271X (DE-588)1125902795 |
| author_facet | Olivier, Kenneth J. Jr. 1968- |
| author_role | aut |
| author_sort | Olivier, Kenneth J. Jr. 1968- |
| author_variant | k j o kj kjo |
| building | Verbundindex |
| bvnumber | BV044557919 |
| classification_rvk | VS 9400 |
| ctrlnum | (OCoLC)974721534 (DE-599)BVBBV044557919 |
| dewey-full | 615.7/98 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.7/98 |
| dewey-search | 615.7/98 |
| dewey-sort | 3615.7 298 |
| dewey-tens | 610 - Medicine and health |
| discipline | Chemie / Pharmazie Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01278nam a2200349zc 4500</leader><controlfield tag="001">BV044557919</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20180409 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">171026s2017 a||| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781119060680</subfield><subfield code="c">Print</subfield><subfield code="9">978-1-119-06068-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)974721534</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV044557919</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-473</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.7/98</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">VS 9400</subfield><subfield code="0">(DE-625)147728:253</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Olivier, Kenneth J.</subfield><subfield code="c">Jr.</subfield><subfield code="d">1968-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)112590271X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Antibody-drug conjugates</subfield><subfield code="b">fundamentals, drug development, and clinical outcomes to target cancer</subfield><subfield code="c">edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Hoboken, New Jersey</subfield><subfield code="b">Wiley</subfield><subfield code="c">[2017]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">xxxiv, 521 Seiten</subfield><subfield code="b">Illustrationen, Diagramme</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antibody-toxin conjugates</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hurvitz, Sara A.</subfield><subfield code="d">1970-</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)1125902795</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-119-06072-7</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-029956597</subfield></datafield></record></collection> |
| id | DE-604.BV044557919 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T07:55:51Z |
| institution | BVB |
| isbn | 9781119060680 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-029956597 |
| oclc_num | 974721534 |
| open_access_boolean | |
| owner | DE-473 DE-BY-UBG DE-19 DE-BY-UBM |
| owner_facet | DE-473 DE-BY-UBG DE-19 DE-BY-UBM |
| physical | xxxiv, 521 Seiten Illustrationen, Diagramme |
| publishDate | 2017 |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| publisher | Wiley |
| record_format | marc |
| spelling | Olivier, Kenneth J. Jr. 1968- Verfasser (DE-588)112590271X aut Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz Hoboken, New Jersey Wiley [2017] xxxiv, 521 Seiten Illustrationen, Diagramme txt rdacontent n rdamedia nc rdacarrier Includes bibliographical references and index MEDICAL / Pharmacology bisacsh Medizin Antibody-toxin conjugates Hurvitz, Sara A. 1970- Sonstige (DE-588)1125902795 oth Erscheint auch als Online-Ausgabe 978-1-119-06072-7 |
| spellingShingle | Olivier, Kenneth J. Jr. 1968- Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer MEDICAL / Pharmacology bisacsh Medizin Antibody-toxin conjugates |
| title | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer |
| title_auth | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer |
| title_exact_search | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer |
| title_full | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz |
| title_fullStr | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz |
| title_full_unstemmed | Antibody-drug conjugates fundamentals, drug development, and clinical outcomes to target cancer edited by Kenneth J. Olivier Jr. and Sara A. Hurvitz |
| title_short | Antibody-drug conjugates |
| title_sort | antibody drug conjugates fundamentals drug development and clinical outcomes to target cancer |
| title_sub | fundamentals, drug development, and clinical outcomes to target cancer |
| topic | MEDICAL / Pharmacology bisacsh Medizin Antibody-toxin conjugates |
| topic_facet | MEDICAL / Pharmacology Medizin Antibody-toxin conjugates |
| work_keys_str_mv | AT olivierkennethj antibodydrugconjugatesfundamentalsdrugdevelopmentandclinicaloutcomestotargetcancer AT hurvitzsaraa antibodydrugconjugatesfundamentalsdrugdevelopmentandclinicaloutcomestotargetcancer |